Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Wuhan Hesheng Technology Co. Ltd. holds a company patent portfolio in the Biotechnology & Pharmaceuticals technology area. The portfolio currently features 1 pending office action, which is assigned to 1 distinct examiner. This prosecution activity is localized within 1 distinct art unit, suggesting a focused technical scope for the company's current filings. For a practitioner, this indicates a specific examination environment where outcomes depend on the interpretation of the assigned official.
The busiest examiner for this portfolio is LOUNTOS, GEORGE THEMISTOCLIS, who is responsible for 1 busiest examiner pending office action. Because the total pending office actions and the busiest examiner pending count are both 1, this examiner currently oversees the entirety of the company's active prosecution. The presence of 1 distinct examiner and 1 distinct art unit reflects the current technical focus. Practitioners should prepare for a consistent examination style given that LOUNTOS, GEORGE THEMISTOCLIS is the official currently engaged with the portfolio. Monitoring the progress of this 1 pending office action will provide insight into how the examiner views the company's biotechnology applications.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LOUNTOS, GEORGE THEMISTOCLIS | 1 | 57.1% | +60.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18860715 | NEROLIDOL SYNTHASE AND USE THEREOF | LOUNTOS, GEORGE THEMISTOCLIS | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18860715 | NEROLIDOL SYNTHASE AND USE THEREOF | LOUNTOS, GEORGE THEMISTOCLIS | — |
| Art Unit | Apps |
|---|---|
| 1652 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18860715 | NEROLIDOL SYNTHASE AND USE THEREOF | LOUNTOS, GEORGE THEMISTOCLIS | 1652 | §101§102§103§112 | Non-Final OA | — | Pending | Dec 16, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialWuhan Hesheng Technology Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
George Themistoclis Lountos has the most, with 1 of Wuhan Hesheng Technology Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
